Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease.

Nutrition (Burbank, Los Angeles County, Calif.) - 1 May 2002

Mark László, Erdei Ferenc, Markizay János, Kondacs András, Katona András

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Dietary Supplements
Share to Folic Acid
Share to Homocysteine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipids

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Vitamin B 6

Source

Identifiers

PMID: 11985950
DOI: 10.1016/s0899-9007(02)00772-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease.PMID 11985950Read ↗

Folic Acid Supplementation Cardiovascular Disease: The State of the ArtSemantic proximity Read ↗

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.Semantic proximity Read ↗

Effect of supplementation with folic-acid on relation between plasma homocysteine, folate, and vitamin B12.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.Semantic proximity Read ↗

C(1) metabolism and CVD outcomes in older adults.Semantic proximity Read ↗

B-vitamins, homocysteine metabolism and CVD.Semantic proximity Read ↗

MTHFR C677T gene polymorphism in patients with coronary heart disease and hypertension treated with enalapril and folic acid: implications for prognosis.Semantic proximity Read ↗

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.Semantic proximity Read ↗

Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy).Semantic proximity Read ↗

Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis?Semantic proximity Read ↗

Elderly women: homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism).Semantic proximity Read ↗

Homocysteine and ischaemic heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.